1 Study Coverage 1.1 Metastatic Melanoma Diagnostic Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) & (US$ Million) Introduction 1.2 Global Metastatic Melanoma Diagnostic Outlook 2017 VS 2022 VS 2028 1.2.1 Global Metastatic Melanoma Diagnostic Market Size for the Year 2017-2028 1.2.2 Global Metastatic Melanoma Diagnostic Market Size for the Year 2017-2028 1.3 Metastatic Melanoma Diagnostic Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Metastatic Melanoma Diagnostic in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Metastatic Melanoma Diagnostic Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Metastatic Melanoma Diagnostic Market Dynamics 1.4.1 Metastatic Melanoma Diagnostic Industry Trends 1.4.2 Metastatic Melanoma Diagnostic Market Drivers 1.4.3 Metastatic Melanoma Diagnostic Market Challenges 1.4.4 Metastatic Melanoma Diagnostic Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Metastatic Melanoma Diagnostic by Type 2.1 Metastatic Melanoma Diagnostic Market Segment by Type 2.1.1 BRAF Mutation 2.1.2 Circulating Tumor Cells (CTCs) 2.1.3 Immunohistochemistry 2.1.4 Others 2.2 Global Metastatic Melanoma Diagnostic Market Size by Type (2017, 2022 & 2028) 2.3 Global Metastatic Melanoma Diagnostic Market Size by Type (2017-2028) 2.4 United States Metastatic Melanoma Diagnostic Market Size by Type (2017, 2022 & 2028) 2.5 United States Metastatic Melanoma Diagnostic Market Size by Type (2017-2028) 3 Metastatic Melanoma Diagnostic by Application 3.1 Metastatic Melanoma Diagnostic Market Segment by Application 3.1.1 Pathology Laboratories 3.1.2 Hospitals 3.1.3 Cancer Research Centres 3.1.4 Others 3.2 Global Metastatic Melanoma Diagnostic Market Size by Application (2017, 2022 & 2028) 3.3 Global Metastatic Melanoma Diagnostic Market Size by Application (2017-2028) 3.4 United States Metastatic Melanoma Diagnostic Market Size by Application (2017, 2022 & 2028) 3.5 United States Metastatic Melanoma Diagnostic Market Size by Application (2017-2028) 4 Global Metastatic Melanoma Diagnostic Competitor Landscape by Company 4.1 Global Metastatic Melanoma Diagnostic Market Size by Company 4.1.1 Top Global Metastatic Melanoma Diagnostic Companies Ranked by Revenue (2021) 4.1.2 Global Metastatic Melanoma Diagnostic Revenue by Player (2017-2022) 4.2 Global Metastatic Melanoma Diagnostic Concentration Ratio (CR) 4.2.1 Metastatic Melanoma Diagnostic Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Metastatic Melanoma Diagnostic in 2021 4.2.3 Global Metastatic Melanoma Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Metastatic Melanoma Diagnostic Headquarters, Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) & (US$ Million) Type 4.3.1 Global Metastatic Melanoma Diagnostic Headquarters and Area Served 4.3.2 Global Metastatic Melanoma Diagnostic Companies Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Metastatic Melanoma Diagnostic Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Metastatic Melanoma Diagnostic Market Size by Company 4.5.1 Top Metastatic Melanoma Diagnostic Players in United States, Ranked by Revenue (2021) 4.5.2 United States Metastatic Melanoma Diagnostic Revenue by Players (2020, 2021 & 2022) 5 Global Metastatic Melanoma Diagnostic Market Size by Region 5.1 Global Metastatic Melanoma Diagnostic Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Metastatic Melanoma Diagnostic Market Size by Region (2017-2028) 5.2.1 Global Metastatic Melanoma Diagnostic Market Size by Region: 2017-2022 5.2.2 Global Metastatic Melanoma Diagnostic Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Metastatic Melanoma Diagnostic Market Size YoY Growth 2017-2028 6.1.2 North America Metastatic Melanoma Diagnostic Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Metastatic Melanoma Diagnostic Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Metastatic Melanoma Diagnostic Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Metastatic Melanoma Diagnostic Market Size YoY Growth 2017-2028 6.3.2 Europe Metastatic Melanoma Diagnostic Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Metastatic Melanoma Diagnostic Market Size YoY Growth 2017-2028 6.4.2 Latin America Metastatic Melanoma Diagnostic Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Metastatic Melanoma Diagnostic Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Metastatic Melanoma Diagnostic Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Myriad Genetics 7.1.1 Myriad Genetics Company Details 7.1.2 Myriad Genetics Business Overview 7.1.3 Myriad Genetics Metastatic Melanoma Diagnostic Introduction 7.1.4 Myriad Genetics Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) 7.1.5 Myriad Genetics Recent Development 7.2 Abbott Laboratories 7.2.1 Abbott Laboratories Company Details 7.2.2 Abbott Laboratories Business Overview 7.2.3 Abbott Laboratories Metastatic Melanoma Diagnostic Introduction 7.2.4 Abbott Laboratories Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) 7.2.5 Abbott Laboratories Recent Development 7.3 Foundation Medicine 7.3.1 Foundation Medicine Company Details 7.3.2 Foundation Medicine Business Overview 7.3.3 Foundation Medicine Metastatic Melanoma Diagnostic Introduction 7.3.4 Foundation Medicine Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) 7.3.5 Foundation Medicine Recent Development 7.4 Pathway Genomics Corporation 7.4.1 Pathway Genomics Corporation Company Details 7.4.2 Pathway Genomics Corporation Business Overview 7.4.3 Pathway Genomics Corporation Metastatic Melanoma Diagnostic Introduction 7.4.4 Pathway Genomics Corporation Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) 7.4.5 Pathway Genomics Corporation Recent Development 7.5 Cancer Genetics 7.5.1 Cancer Genetics Company Details 7.5.2 Cancer Genetics Business Overview 7.5.3 Cancer Genetics Metastatic Melanoma Diagnostic Introduction 7.5.4 Cancer Genetics Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) 7.5.5 Cancer Genetics Recent Development 7.6 Castle Biosciences 7.6.1 Castle Biosciences Company Details 7.6.2 Castle Biosciences Business Overview 7.6.3 Castle Biosciences Metastatic Melanoma Diagnostic Introduction 7.6.4 Castle Biosciences Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) 7.6.5 Castle Biosciences Recent Development 7.7 NeoGenomics 7.7.1 NeoGenomics Company Details 7.7.2 NeoGenomics Business Overview 7.7.3 NeoGenomics Metastatic Melanoma Diagnostic Introduction 7.7.4 NeoGenomics Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) 7.7.5 NeoGenomics Recent Development 7.8 Dermtech 7.8.1 Dermtech Company Details 7.8.2 Dermtech Business Overview 7.8.3 Dermtech Metastatic Melanoma Diagnostic Introduction 7.8.4 Dermtech Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) 7.8.5 Dermtech Recent Development 7.9 Sysmex Inostics 7.9.1 Sysmex Inostics Company Details 7.9.2 Sysmex Inostics Business Overview 7.9.3 Sysmex Inostics Metastatic Melanoma Diagnostic Introduction 7.9.4 Sysmex Inostics Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) 7.9.5 Sysmex Inostics Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Metastatic Melanoma Diagnostic Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Metastatic Melanoma Diagnostic Market Trends Table 3. Metastatic Melanoma Diagnostic Market Drivers Table 4. Metastatic Melanoma Diagnostic Market Challenges Table 5. Metastatic Melanoma Diagnostic Market Restraints Table 6. Global Metastatic Melanoma Diagnostic Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Metastatic Melanoma Diagnostic Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Metastatic Melanoma Diagnostic Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Metastatic Melanoma Diagnostic Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Metastatic Melanoma Diagnostic Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Metastatic Melanoma Diagnostic Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Metastatic Melanoma Diagnostic Revenue Share by Player, 2017-2022 Table 13. Global Metastatic Melanoma Diagnostic Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Metastatic Melanoma Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Melanoma Diagnostic as of 2021) Table 15. Top Players of Metastatic Melanoma Diagnostic in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Metastatic Melanoma Diagnostic Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Metastatic Melanoma Diagnostic Players in United States Market, Ranking by Revenue (2021) Table 20. United States Metastatic Melanoma Diagnostic Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Metastatic Melanoma Diagnostic Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Metastatic Melanoma Diagnostic Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Metastatic Melanoma Diagnostic Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Metastatic Melanoma Diagnostic Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Metastatic Melanoma Diagnostic Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Metastatic Melanoma Diagnostic Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Metastatic Melanoma Diagnostic Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Metastatic Melanoma Diagnostic Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Metastatic Melanoma Diagnostic Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Myriad Genetics Company Details Table 31. Myriad Genetics Business Overview Table 32. Myriad Genetics Metastatic Melanoma Diagnostic Product Table 33. Myriad Genetics Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) & (US$ Million) Table 34. Myriad Genetics Recent Development Table 35. Abbott Laboratories Company Details Table 36. Abbott Laboratories Business Overview Table 37. Abbott Laboratories Metastatic Melanoma Diagnostic Product Table 38. Abbott Laboratories Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) & (US$ Million) Table 39. Abbott Laboratories Recent Development Table 40. Foundation Medicine Company Details Table 41. Foundation Medicine Business Overview Table 42. Foundation Medicine Metastatic Melanoma Diagnostic Product Table 43. Foundation Medicine Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) & (US$ Million) Table 44. Foundation Medicine Recent Development Table 45. Pathway Genomics Corporation Company Details Table 46. Pathway Genomics Corporation Business Overview Table 47. Pathway Genomics Corporation Metastatic Melanoma Diagnostic Product Table 48. Pathway Genomics Corporation Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) & (US$ Million) Table 49. Pathway Genomics Corporation Recent Development Table 50. Cancer Genetics Company Details Table 51. Cancer Genetics Business Overview Table 52. Cancer Genetics Metastatic Melanoma Diagnostic Product Table 53. Cancer Genetics Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) & (US$ Million) Table 54. Cancer Genetics Recent Development Table 55. Castle Biosciences Company Details Table 56. Castle Biosciences Business Overview Table 57. Castle Biosciences Metastatic Melanoma Diagnostic Product Table 58. Castle Biosciences Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) & (US$ Million) Table 59. Castle Biosciences Recent Development Table 60. NeoGenomics Company Details Table 61. NeoGenomics Business Overview Table 62. NeoGenomics Metastatic Melanoma Diagnostic Product Table 63. NeoGenomics Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) & (US$ Million) Table 64. NeoGenomics Recent Development Table 65. Dermtech Company Details Table 66. Dermtech Business Overview Table 67. Dermtech Metastatic Melanoma Diagnostic Product Table 68. Dermtech Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) & (US$ Million) Table 69. Dermtech Recent Development Table 70. Sysmex Inostics Company Details Table 71. Sysmex Inostics Business Overview Table 72. Sysmex Inostics Metastatic Melanoma Diagnostic Product Table 73. Sysmex Inostics Revenue in Metastatic Melanoma Diagnostic Business (2017-2022) & (US$ Million) Table 74. Sysmex Inostics Recent Development Table 75. Research Programs/Design for This Report Table 76. Key Data Information from Secondary Sources Table 77. Key Data Information from Primary Sources List of Figures Figure 1. Metastatic Melanoma Diagnostic Product Picture Figure 2. Global Metastatic Melanoma Diagnostic Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Metastatic Melanoma Diagnostic Market Size 2017-2028 (US$ Million) Figure 4. United States Metastatic Melanoma Diagnostic Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Metastatic Melanoma Diagnostic Market Size 2017-2028 (US$ Million) Figure 6. United States Metastatic Melanoma Diagnostic Market Share in Global 2017-2028 Figure 7. Metastatic Melanoma Diagnostic Report Years Considered Figure 8. Product Picture of BRAF Mutation Figure 9. Product Picture of Circulating Tumor Cells (CTCs) Figure 10. Product Picture of Immunohistochemistry Figure 11. Product Picture of Others Figure 12. Global Metastatic Melanoma Diagnostic Market Share by Type in 2022 & 2028 Figure 13. Global Metastatic Melanoma Diagnostic Market Size by Type (2017-2028) & (US$ Million) Figure 14. Global Metastatic Melanoma Diagnostic Market Share by Type (2017-2028) Figure 15. United States Metastatic Melanoma Diagnostic Market Share by Type in 2022 & 2028 Figure 16. United States Metastatic Melanoma Diagnostic Market Size by Type (2017-2028) & (US$ Million) Figure 17. United States Metastatic Melanoma Diagnostic Market Share by Type (2017-2028) Figure 18. Product Picture of Pathology Laboratories Figure 19. Product Picture of Hospitals Figure 20. Product Picture of Cancer Research Centres Figure 21. Product Picture of Others Figure 22. Global Metastatic Melanoma Diagnostic Market Share by Application in 2022 & 2028 Figure 23. Global Metastatic Melanoma Diagnostic Market Size by Application (2017-2028) & (US$ Million) Figure 24. Global Metastatic Melanoma Diagnostic Market Share by Application (2017-2028) Figure 25. United States Metastatic Melanoma Diagnostic Market Share by Application in 2022 & 2028 Figure 26. United States Metastatic Melanoma Diagnostic Market Size by Application (2017-2028) & (US$ Million) Figure 27. United States Metastatic Melanoma Diagnostic Market Share by Application (2017-2028) Figure 28. North America Metastatic Melanoma Diagnostic Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. U.S. Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. Canada Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. Europe Metastatic Melanoma Diagnostic Market Size Growth Rate 2017-2028 (US$ Million) Figure 32. Germany Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. France Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. U.K. Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Italy Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Russia Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. Asia-Pacific Metastatic Melanoma Diagnostic Market Size Growth Rate 2017-2028 (US$ Million) Figure 38. China Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Japan Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. South Korea Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. India Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Australia Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Taiwan Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Indonesia Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Thailand Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Malaysia Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Philippines Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Latin America Metastatic Melanoma Diagnostic Market Size Growth Rate 2017-2028 (US$ Million) Figure 49. Mexico Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Brazil Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Argentina Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Middle East & Africa Metastatic Melanoma Diagnostic Market Size Growth Rate 2017-2028 (US$ Million) Figure 53. Turkey Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. U.A.E Metastatic Melanoma Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 56. Myriad Genetics Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2017-2022) Figure 57. Abbott Laboratories Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2017-2022) Figure 58. Foundation Medicine Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2017-2022) Figure 59. Pathway Genomics Corporation Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2017-2022) Figure 60. Cancer Genetics Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2017-2022) Figure 61. Castle Biosciences Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2017-2022) Figure 62. NeoGenomics Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2017-2022) Figure 63. Dermtech Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2017-2022) Figure 64. Sysmex Inostics Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2017-2022) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Myriad Genetics Abbott Laboratories Foundation Medicine Pathway Genomics Corporation Cancer Genetics Castle Biosciences NeoGenomics Dermtech Sysmex Inostics